JP2020536554A5 - - Google Patents

Download PDF

Info

Publication number
JP2020536554A5
JP2020536554A5 JP2020520317A JP2020520317A JP2020536554A5 JP 2020536554 A5 JP2020536554 A5 JP 2020536554A5 JP 2020520317 A JP2020520317 A JP 2020520317A JP 2020520317 A JP2020520317 A JP 2020520317A JP 2020536554 A5 JP2020536554 A5 JP 2020536554A5
Authority
JP
Japan
Prior art keywords
hsa
mir
population
item
msc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020520317A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020536554A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/055092 external-priority patent/WO2019074980A1/en
Publication of JP2020536554A publication Critical patent/JP2020536554A/ja
Publication of JP2020536554A5 publication Critical patent/JP2020536554A5/ja
Priority to JP2023173609A priority Critical patent/JP2023171952A/ja
Pending legal-status Critical Current

Links

JP2020520317A 2017-10-09 2018-10-09 細胞集団を増大させるための方法および組成物 Pending JP2020536554A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023173609A JP2023171952A (ja) 2017-10-09 2023-10-05 細胞集団を増大させるための方法および組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762570076P 2017-10-09 2017-10-09
US62/570,076 2017-10-09
US201862695820P 2018-07-09 2018-07-09
US62/695,820 2018-07-09
PCT/US2018/055092 WO2019074980A1 (en) 2017-10-09 2018-10-09 METHODS AND COMPOSITIONS FOR EXPANSION OF CELL POPULATION

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023173609A Division JP2023171952A (ja) 2017-10-09 2023-10-05 細胞集団を増大させるための方法および組成物

Publications (2)

Publication Number Publication Date
JP2020536554A JP2020536554A (ja) 2020-12-17
JP2020536554A5 true JP2020536554A5 (enExample) 2021-11-18

Family

ID=66101161

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020520317A Pending JP2020536554A (ja) 2017-10-09 2018-10-09 細胞集団を増大させるための方法および組成物
JP2023173609A Pending JP2023171952A (ja) 2017-10-09 2023-10-05 細胞集団を増大させるための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023173609A Pending JP2023171952A (ja) 2017-10-09 2023-10-05 細胞集団を増大させるための方法および組成物

Country Status (6)

Country Link
US (1) US12359200B2 (enExample)
EP (1) EP3694533A4 (enExample)
JP (2) JP2020536554A (enExample)
KR (1) KR102733714B1 (enExample)
CN (2) CN120366217A (enExample)
WO (1) WO2019074980A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11046969B2 (en) 2017-05-24 2021-06-29 Epiplanta Biotech Ltd. Transgenic plant and the method for producing the same
JP2020536554A (ja) 2017-10-09 2020-12-17 ストワーズ インスティテュート フォー メディカル リサーチ 細胞集団を増大させるための方法および組成物
WO2021003330A1 (en) * 2019-07-03 2021-01-07 Children's Medical Center Corporation Inhibiting the rna methyltransferase mettl3 or its interaction with eif3h to suppress oncogene translation and tumorigenesis
CN115884781A (zh) * 2020-06-09 2023-03-31 杭州领知医药科技有限公司 用于增强免疫应答的组合物和方法
EP4178586A4 (en) * 2020-07-09 2024-10-09 Shanghai Institute of Materia Medica, Chinese Academy of Sciences Compositions and methods for inhibiting ythdf1
WO2022055971A1 (en) * 2020-09-09 2022-03-17 Duke University Methods for reprogramming target cells
US20230383292A1 (en) * 2020-10-19 2023-11-30 The General Hospital Corporation Targeting xist and rna methylation for x reactivation therapy
CN112941102A (zh) * 2021-01-26 2021-06-11 南方医科大学 一种子痫前期小鼠动物模型的构建方法及其应用
CN112941105A (zh) * 2021-02-08 2021-06-11 江西农业大学 一种m6A“阅读器”YTHDF2基因改造方法及其应用
CN112899238B (zh) * 2021-04-01 2023-09-26 中国药科大学 基于RNA-m6A修饰水平的化合物筛选细胞模型及其构建与应用
WO2022241165A2 (en) * 2021-05-12 2022-11-17 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods of use for mutated hotair in the treatment of cancers
CN116024326A (zh) * 2022-09-21 2023-04-28 安徽中医药大学第一附属医院(安徽省中医院) 类风湿关节炎m6A甲基化修饰基因PTEN的应用及其检测方法
CN115463155B (zh) * 2022-11-01 2023-05-23 卡瑞济(北京)生命科技有限公司 间充质干细胞的用途
WO2024151006A1 (ko) * 2023-01-09 2024-07-18 한국생명공학연구원 Fto 유전자의 발현이 억제된 줄기세포 및 이로부터 분화된 면역세포
KR20260007568A (ko) * 2023-03-31 2026-01-14 주식회사 바이오오케스트라 Mirna-484 억제제 및 이의 용도
WO2025117708A2 (en) * 2023-11-28 2025-06-05 Baruch S. Blumberg Institute Method and system for use of mutant mrna in liquid biopsies to risk stratify and manage cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0462145T3 (da) 1989-03-07 1994-08-08 Genentech Inc Covalente konjugater mellem lipid og oligonucleotid
WO1991004753A1 (en) 1989-10-02 1991-04-18 Cetus Corporation Conjugates of antisense oligonucleotides and therapeutic uses thereof
US7018801B2 (en) 2000-02-11 2006-03-28 Board Of Regents, The University Of Texas System Selection of peptides with antibody-like properties
US20070065447A1 (en) 2003-10-29 2007-03-22 Novo Nordisk A/S Laminin-5 gamma2-binding peptides, related compositions, and use thereof
EP2798956A1 (en) * 2007-04-23 2014-11-05 Stowers Institute for Medical Research Methods and compositions for hematopoeitic stem cell self-renewal
CN103124784A (zh) * 2010-08-23 2013-05-29 纽约州立大学研究基金会 用于扩增干细胞的方法和这些细胞的用途
US9920317B2 (en) * 2010-11-12 2018-03-20 The General Hospital Corporation Polycomb-associated non-coding RNAs
RU2728867C2 (ru) 2011-04-20 2020-07-31 Де Реджентс Оф Де Юниверсити Оф Калифорния Способ совместного кондиционирования и хемоселекции за один цикл
CN107207557B (zh) * 2015-01-26 2020-07-10 中国科学院动物研究所 miRNA对m6A修饰水平的调控方法及其应用
US20160264934A1 (en) * 2015-03-11 2016-09-15 The General Hospital Corporation METHODS FOR MODULATING AND ASSAYING m6A IN STEM CELL POPULATIONS
JP2020536554A (ja) 2017-10-09 2020-12-17 ストワーズ インスティテュート フォー メディカル リサーチ 細胞集団を増大させるための方法および組成物

Similar Documents

Publication Publication Date Title
KR102733714B1 (ko) 세포 집단의 증대를 위한 방법 및 조성물
KR101960067B1 (ko) 마이크로 rna를 유효 성분으로 포함하는 암 치료용 약학 조성물
DK2416789T3 (en) Method and apparatus for treating diseases associated with inflammation or unwanted activation of the immune system
DK2475372T3 (en) Process for Preparation of Micro-RNA and Its Therapeutic Use
CA2687336C (en) Micro-rna scaffolds and non-naturally occurring micro-rnas
US11602568B2 (en) Engineered B lymphocytes and compositions having micro-RNA and methods for making and using them
US12018256B2 (en) Method for modifying genes
CN103476947A (zh) 寡聚体的增强的生物分布
JP2015529450A (ja) 幹細胞微粒子
US11041201B2 (en) Methods for detection of RNase activity
Cho et al. MicroRNA expression profiling in neurogenesis of adipose tissue-derived stem cells
Efimenko et al. Data supporting that miR-92a suppresses angiogenic activity of adipose-derived mesenchymal stromal cells by down-regulating hepatocyte growth factor
HK40031696B (zh) 用於扩增细胞群的方法和组合物
Omnibus AUC: area under curve. KEGG: Kyoto Encyclopedia of Genes and Genomes. GEO: Gene
HK40031696A (en) Methods and compositions for expansion of cell population